Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...

Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible ...

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology and immunology therapies, announced IMULDOSA® (ustekinumab-srlf) is now covered by ...

Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.

Researchers used AI and experimental models to identify existing drugs as potential treatments for Leigh Syndrome, ...

Real-world persistence data for tildrakizumab paint an encouraging picture of long-term treatment durability, with ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...

Psoriasis, affecting over a million people across Britain, may put those living with the condition and their family members ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...

What happens when something once associated with healing suddenly feels dangerous? A diagnosis can change identity, perception, and daily life.

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...

Psoriatic arthritis affects around one in five people with psoriasis, according to Psoriasis Association UK. The two key ...